Apyx Medical prelim Q4 rev $14.1-14.3M; Advanced Energy up >25% QoQ

Apyx Medical Corp

Total Q4 revenue $14.1-14.3M, down ~3-4% YoY; Advanced Energy ~$12.0-12.2M (flat YoY).
Full-year 2024 revenue $48.0-48.2M, down 8% YoY; Advanced Energy down 11% to $38.5-38.7M.
OEM revenue Q4 $2.1M (-17% YoY); full-year $9.5M (+6% YoY).
New AYON Body Contouring System expected to launch H2 2025 pending FDA clearance.
CEO cites doubled U.S. generator unit sales in H2 vs H1 and GLP-1-driven demand for skin treatments.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.